bioconjugation

Lonza Doubles Capacity Adds 200 Jobs in Switzerland!

Lonza expands its Visp facility with two new bioconjugation suites, creating 200 jobs and doubling capacity for antibody-drug conjugates! 🌍🏗️💼📈🌱